1. Share Prices

  2. Astrazeneca PLC (AZN)

12,508.00p-20.00 (-0.16%)05 Nov 2025, 09:13
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.AJ Bell logo
Jump to:

Astrazeneca PLC Fundamentals

Company NameAstrazeneca PLCLast Updated2025-11-05
IndustryDrug Manufacturers - GeneralSectorHealthcare
Shares in Issue1.550 bnMarket Cap£194.03 bn
PE Ratio30.58Dividend per Share$2.99
Dividend Yield1.98Dividend Cover1.50
EPS$4.50EPS Growth (%)0.12
PEG0.95DPS Growth (%)0.0409
Debt Ratio0.2921Debt Equity Ratio0.5811
Asset Equity Ratio2.5089Cash Equity Ratio0.1586
Quick Ratio0.6344Current Ratio0.86
Price To Book Value5.7045ROCE0

Astrazeneca PLC Dividends

TypeEx-DatePay DateCurrencyNet DividendYear Total
Interim2025-08-072025-09-08GBP0.7670
Prelim2025-02-202025-03-24GBP1.6800
Interim2024-08-082024-09-09GBP0.7760
Prelim2024-02-222024-03-25GBP1.5600
Interim2023-08-102023-09-11GBP0.7180
Prelim2023-02-232023-03-27GBP1.6280

Astrazeneca PLC Company Financials

Assets202420232022
Tangible Assets$11.65 bn$10.50 bn$9.45 bn
Intangible Assets$58.20 bn$58.14 bn$59.13 bn
Investments$1.90 bn$1.68 bn$1.14 bn
Total Fixed Assets$78.21 bn$76.06 bn$73.89 bn
Stocks$5.29 bn$5.42 bn$4.70 bn
Debtors$11.23 bn$10.51 bn$9.19 bn
Cash & Equivalents$5.53 bn$5.86 bn$6.24 bn
Other Assets$6.46 bn$5.75 bn$4.17 bn
Total Assets$104.03 bn$101.12 bn$96.48 bn
Liabilities202420232022
Creditors within 1 year$27.87 bn$30.54 bn$26.29 bn
Creditors after 1 year$35.30 bn$31.41 bn$33.13 bn
Other Liabilities000
Total Liabilities$63.16 bn$61.95 bn$59.42 bn
Net assets$40.87 bn$39.17 bn$37.06 bn
Equity202420232022
Called up share capital$388.00 m$388.00 m$387.00 m
Share Premium$35.38 bn$35.34 bn$35.31 bn
Profit / Loss$8.69 bn$6.90 bn$2.50 bn
Other Equity$40.79 bn$39.14 bn$37.04 bn
Preference & Minorities$85.00 m$23.00 m$21.00 m
Total Capital Employed$40.87 bn$39.17 bn$37.06 bn
Ratios202420232022
Debt Ratio$0.40$0.37$0.39
Debt-to-Equity$0.68$0.59$0.64
Assets / Equity2.50892.50892.5089
Cash / Equity0.15860.15860.1586
EPS$4.62$4.11$2.51
Cash Flow202420232022
Cash from operating activities$11.86 bn$10.35 bn$9.81 bn
Cashflow before financing$7.87 bn$3.78 bn$2.98 bn
Increase in Cash-$115.00 m-$286.00 m$25.00 m
Income202420232022
Turnover$54.07 bn$45.81 bn$44.35 bn
Cost of sales$10.21 bn$8.27 bn$12.39 bn
Gross Profit$43.87 bn$37.54 bn$31.96 bn
Operating Profit$10.00 bn$8.19 bn$3.76 bn
Pre-Tax profit$8.69 bn$6.90 bn$2.50 bn

Astrazeneca PLC Company Background

SectorHealthcare
ActivitiesA merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
Latest Interim Date29 Jul 2025
Latest Fiscal Year End Date6 Feb 2025

Astrazeneca PLC Directors

AppointedNamePosition
2016-12-01Mr. Jean-Philippe CourtoisNon-Executive Independent Director
2010-11-16Ms. Michele J. HooperNon-Executive Director
1995-04-11Sir Peter Leahy Bonfield CBENon-Executive Director
2019-04-26Mr. Rudolph Harold Peter MarkhamNon-Executive Director
2025-02-18Ms. Sherilyn S. McCoyNon-Executive Director
2010-10-29Dr. Jane E Henney, M.D.Non-Executive Director
2019-03-07Mr. David R. BrennanDirector and Chief Executive Officer
2025-04-11Dr. Andreas RummeltNon-Executive Director
2009-10-30Mr. Bo AngelinNon-Executive Director
2000-12-22Ms. Erna MollerNon-Executive Director
2011-11-16Dr. Hakan L. MogrenNon-Executive Deputy Chairman
2015-04-24Dr. John Silvester Varley Non-Executive Director
2011-08-09Sir Jonathan Richard Symonds CBEExecutive Director,Chief Financial Officer
2024-02-20Mr. Leif JohanssonNon-Executive Director,Chairman
2012-06-01Mr. Louis SchweitzerNon-Executive Director,Chairman
2022-02-22Mr. Marc DunoyerExecutive Director,Chief Financial Officer
2025-02-18Mr. Marcus WallenbergNon-Executive Director
2025-02-18Mr. Michel DemareNon-Executive Director,Chairman
2025-05-23Mr. Pascal SoriotExecutive Director,Chief Executive Officer
2025-02-18Mr. Philip A J BroadleyNon-Executive Director,Senior Independent Director
2014-03-20Mr. Simon Jonathan LowthExecutive Director,Chief Financial Officer
2011-08-09Dr. John Simon Patterson, CBEExecutive Director
2015-04-24Professor Dame Nancy RothwellNon-Executive Director
2005-08-25Sir John BuchananNon-Executive Director
2023-02-21Mr. Graham Andrew Chipchase, C.B.E.Non-Executive Director,Senior independent Director
2023-02-21Ms. Genevieve BergerNon-Executive Director
2017-11-13Dr. Bruce BurlingtonNon-Executive Director
2003-09-08Mr. Joe JimenezNon-Executive Director
2019-03-05Baroness Shriti Vadera Non-Executive Independent Director
2017-04-27Ms. Ann CairnsNon-Executive Independent Director
2025-02-18Ms. Diana LayfieldNon-Executive Director
2025-04-11Ms. Deborah DiSanzoNon-Executive Director
2025-02-18Ms. Anna Olive Magdelene Manz Non-Executive Director
2016-09-30Dr. Cornelia BargmannNon-Executive Director
2025-02-18Professor Nazneen RahmanNon-Executive Director
2025-08-18Dr. Aradhana SarinExecutive Director,Chief Financial Officer
2025-02-18Professor Tony MokNon-Executive Director
2025-02-18Dr. Euan AshleyNon-Executive Director
2025-09-25Ms. Karen KnudsenNon-Executive Director

Astrazeneca PLC Contact Details

Company NameAstraZeneca PLC
Address2 Kingdom Street, London, W2 6BD
Telephone+44 2076048000
Websitehttps://www.astrazeneca.com

Astrazeneca PLC Advisors

AuditorKPMG
Phone+44 2073111000
Fax+44 2073113311
Remuneration ConsultantDeloitte LLP
Phone+44 2079363000
Fax+44 2075831198
Financial PR AdviserFinsbury
Phone+44 2072513801
Fax+44 2073744133
BankCitibank
Phone+44 2075005500
BankHSBC Bank PLC
RegistrarEquiniti Ltd.
Phone+44 1214157082
SolicitorFreshfields Bruckhaus Deringer
Phone+44 2079364000
Fax+44 2078327001
StockbrokerGoldman Sachs International
Phone+44 2077741000
StockbrokerMorgan Stanley & Co International PLC
Phone+44 2074258000
Fax+44 2074258990
AuditorKPMG AUDIT PLC
AuditorKPMG LLP
Phone+1 212 758-9700
Fax+1 212 758-9819
AuditorKPMG Klynveld Peat Marwick Goerdeler SA

Most Read

Receive our
daily news email

Subscribe to the latest investing news by entering your email address below

You can opt out at any time.

For five days a week you will get

  • The latest company news
  • Insight into investment trends
  • Round-up of director's buys and sells
  • Articles from Shares magazine
Sharesmagazine cover

Plus more useful investment content and occasional promotional offers.

Shares Magazine Latest Issue Cover
Latest Issue:
25 Sep 2025

Market Overview

UK 350 Risers and Fallers

Risers

CompanyPrice% Chg
Ceres Power Holdings PLC350.0011.89
Trainline PLC273.657.57
Bluefield Solar Income Fund Limited77.076.75
Metro Bank Holdings PLC115.736.18
Lancashire Holdings Limited672.004.02
International Workplace Group PLC220.602.60

Fallers

CompanyPrice% Chg
Tp Icap Group PLC249.00-4.96
Playtech PLC239.00-3.43
Weir Group PLC2,794.00-2.99
Raspberry Pi Holdings PLC341.00-2.29
Oxford Biomedica PLC664.17-2.61
Allianz Technology Trust PLC526.10-1.85